YLT192
YLT192 is an orally bioavailable small molecule inhibitor targeting VEGFR2, demonstrating potent antiangiogenic and antitumor activity. It is utilized in cancer research, showing efficacy in both in vitro assays and in vivo tumor models for studying angiogenesis and tumor growth inhibition.
Product Specifications
CAS Number
1246566-47-1
Field of Research
Cardiovascular Research, Signal Transduction
Smiles
O (C=1C=C (C (NC) =O) N=CC1) C2=CC=C (NC (=O) C3=CC (OC) =CC=C3) C=C2
Molecular Formula
C21H19N3O4
Molecular Weight
377.39
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
130055-FITC 100 µL
MYL3 (Myosin Light Chain 3, Cardiac Myosin Light Chain 1, Myosin Light Chain 1, Slow-twitch Muscle B/Ventricular Isoform, Ventricular/Slow Twitch Myosin Alkali Light Chain) (FITC)
Sign In for Pricing
View Details 
RDR-SELE-b-48Tests 48 Tests
Bovine Selectin, Endothelium (SELE) ELISA Kit
Sign In for Pricing
View Details